Prehabilitation for Kidney Transplant Candidates (NCT06886256)
Enabling Access to Prehabilitation for Kidney Transplant Candidates Who Are Frail
🩺 Plain-English Summary (8th-Grade Level)
This interventional trial seeks to determine the feasibility of wearable sensors to provide data from patients while undergoing supervised exercise.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (4 items).
Location: Houston Methodist Hospital System — Houston, Texas
Age range: 55 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Inability or contraindication to exercise
- Refusal to participate
- Inability to consent or effectively communicate
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Houston Methodist Hospital System — Houston, Texas
📞 Contact the Study Coordinator
Phone: (713) 441-6232
Email: dwcleere@houstonmethodist.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kidney Transplantation
- Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. — Phoenix, Arizona
- REgulatory T Cell Therapy to Achieve Immunosuppression REduction — Phoenix, Arizona
- Envarsus XR® in Adolescent Renal Transplant Recipients — Los Angeles, California
- The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients — Pittsburgh, Pennsylvania
- Watermelon/UBIQuinone Study — San Francisco, California
Explore by condition: All Kidney Transplantation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.